eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
.
. she suffered a "third brain bleed" and was pronounced brain dead on monday.
.imagine a congressional hearing held before media cameras, with reporters all over the us and europe ready with shocking articles about one of the leading causes of death�
.
thanks for signing up as a global citizen. in order to create your account we need you to provide your email address. you can check out our
.